Market News

Nestle India reported a 26% rise in Q4 profit to ₹1,114 crore, beating estimates, as revenue grew 22.6% on strong volumes, higher ad spends and broad-based category growth.

Biocon received Health Canada approval for denosumab biosimilars Bosaya and Vevzuo, targeting osteoporosis and cancer-related bone conditions. Shares rose over 1% on the NSE following the announcement.

On 21 April 2026, markets saw strong buying across the board and ended higher. Global cues played their part. From here, the focus is on whether this strength continues.

Vedanta confirmed May 1, 2026, as the record date for its demerger, detailing a 1:1 share allotment across four entities: aluminium, power, oil and gas and iron and steel businesses.

PNB Housing Finance posted a 19% rise in Q4 FY26 net profit to ₹656 crore, with disbursements at an all-time high, gross NPA below 1% and final dividend proposed at ₹8.

Indian markets are set for stock-specific moves amid Q4 earnings and Middle East tensions. Key stocks in focus include Vedanta, PNB Housing Finance, TVS Motor, JSW Steel, and others.

The Indian stock market indices opened higher on Tuesday amid mixed global cues. Reports of fresh peace talks between the US and Iran, combined with higher US markets, have resulted in positive sentiments.

Revenue growth was strong in SML Mahindra’s Q4 results, but margins slipped as costs increased. The stock fell after the announcement. From here, margin trends could be the key thing to track.

A report from Ember found clean power generation to rise 887 TWh in 2025. It exceeded electricity demand growth of 849 TWh, as solar and wind expansion in China and India drove a structural shift.

Health insurance premiums may rise 10–15% as medical inflation stays high. Family floater costs have surged 46% since 2021. Read more to understand what this means.

Sensex added 27 points and Nifty rose 11 to 24,365, while GIFT Nifty near 24,423 points to a flat, range-bound start on 21 April 2026 amid rising oil prices and fresh tensions around the US–Iran situation.

Indosolar's Q4 results were a mixed bag as the profit margin increased while the revenue dropped 56.7%. The market's response was pessimistic as the stock tumbled by almost 5% after the announcement.